Allogene Therapeutics, Inc. (ALLO)
0.8075
-0.03
(-3.72%)
USD |
NASDAQ |
Nov 16, 16:00
0.8075
0.00 (0.00%)
After-Hours: 18:57
Allogene Therapeutics Price : 0.8075 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.839 | 0.8654 | 0.8201 | 0.8387 | 11.66M |
| Nov 12, 2026 | 0.89 | 0.8969 | 0.8215 | 0.827 | 10.69M |
| Nov 11, 2026 | 0.955 | 0.96 | 0.88 | 0.9001 | 15.37M |
| Nov 10, 2026 | 1.04 | 1.04 | 0.8901 | 0.9319 | 22.87M |
| Nov 09, 2026 | 1.10 | 1.10 | 1.00 | 1.06 | 10.77M |
| Nov 06, 2026 | 1.09 | 1.13 | 0.98 | 1.04 | 12.63M |
| Nov 05, 2026 | 1.18 | 1.19 | 1.05 | 1.09 | 15.29M |
| Nov 04, 2026 | 1.16 | 1.20 | 1.12 | 1.19 | 16.53M |
| Nov 03, 2026 | 1.12 | 1.14 | 1.10 | 1.12 | 17.67M |
| Nov 02, 2026 | 1.23 | 1.23 | 1.07 | 1.09 | 10.06M |
| Oct 30, 2026 | 1.24 | 1.258 | 1.16 | 1.18 | 9.760M |
| Oct 29, 2026 | 1.33 | 1.38 | 1.25 | 1.25 | 7.715M |
| Oct 28, 2026 | 1.22 | 1.335 | 1.21 | 1.30 | 10.32M |
| Oct 27, 2026 | 1.21 | 1.26 | 1.17 | 1.23 | 16.10M |
| Oct 26, 2026 | 1.26 | 1.27 | 1.19 | 1.21 | 10.58M |
| Oct 23, 2026 | 1.23 | 1.255 | 1.16 | 1.25 | 8.405M |
| Oct 22, 2026 | 1.32 | 1.33 | 1.22 | 1.25 | 8.297M |
| Oct 21, 2026 | 1.33 | 1.365 | 1.31 | 1.33 | 4.742M |
| Oct 20, 2026 | 1.30 | 1.35 | 1.29 | 1.33 | 4.580M |
| Oct 19, 2026 | 1.30 | 1.33 | 1.26 | 1.30 | 5.906M |
| Oct 16, 2026 | 1.34 | 1.34 | 1.29 | 1.31 | 4.919M |
| Oct 15, 2026 | 1.33 | 1.37 | 1.30 | 1.34 | 4.515M |
| Oct 14, 2026 | 1.28 | 1.308 | 1.22 | 1.30 | 7.737M |
| Oct 13, 2026 | 1.39 | 1.395 | 1.29 | 1.29 | 6.544M |
| Oct 12, 2026 | 1.45 | 1.46 | 1.39 | 1.40 | 4.316M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oncolytics Biotech, Inc. | 0.3418 |
| Sangamo Therapeutics, Inc. | 0.117 |
| Sarepta Therapeutics, Inc. | 15.13 |
| Anixa Biosciences, Inc. | 2.57 |
| Vicapsys Life Sciences, Inc. | 0.50 |
Price Related Metrics
| PS Ratio | 49.66 |
| Price to Book Value | 0.7123 |
| Earnings Yield | -77.30% |
| Market Cap | 279.62M |